Related Experiment Video
Updated: Apr 16, 2026

Treatment with Vancomycin Loaded Calcium Sulphate and Autogenous Bone in an Improved Rabbit Model of Bone Infection
Published on: March 14, 2019
Empiric vancomycin use in febrile neutropenic oncology patients
Jessica Libuit1, Andrew Whitman1, Rebecca Wolfe1
1Virginia Commonwealth University School of Pharmacy, Falls Church, Virginia.
Abstract:
Vancomycin is commonly added as empiric therapy for febrile neutropenia. A retrospective chart review was conducted at a large community teaching institution to evaluate vancomycin use in oncology patients. The results revealed that a majority of empiric vancomycin therapy was inappropriate, raising concern for antibiotic resistance and prompting opportunities for improvement.
Related Concept Videos
Treatment Resistent Cancers
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Antimicrobial Effectiveness
Urinary Tract Infection IV: Nursing Management
Drug Dosing: Geriatric Patients
Acute Pyelonephritis II: Diagnostic Studies and Management